Investor Materials

Thumb Date Download

February 1, 2021 Corporate Presentation 2.14 MB

April 8, 2020 2019 Annual Report 1.46 MB

January 1, 2018 2018 Annual Report 939 KB

December 31, 2017 2017 Annual Report 3.18 MB

July 24, 2016 2016 Annual Report 4.75 MB

July 23, 2016 2015 Annual Report 5.24 MB

July 21, 2016 2014 Annual Report 2.13 MB

Recent News

Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $700 Million of Convertible Senior Notes due 2027 02/24/21

Halozyme Therapeutics, Inc. Announces Proposed Offering of $500 Million of Convertible Senior Notes due 2027 02/23/21

Halozyme Reports Fourth Quarter 2020 Results And Full Year 2020 Results 02/23/21

Halozyme To Host Fourth Quarter And Full Year 2020 Financial Results Webcast And Conference Call 02/10/21

Al Kildani
Vice President, Investor Relations
& Corporate Communications
Phone: 858-704-8122
Email: akildani@halozyme.com
media@halozyme.com
ir@halozyme.com

You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.